Adagio Medical (NASDAQ:ADGM) Shares Up 11.5% – Should You Buy?

Adagio Medical Holdings, Inc. (NASDAQ:ADGM) shares rose 11.5% during trading on Tuesday . The stock traded as high as $1.3732 and last traded at $1.26. Approximately 157,548 shares were traded during mid-day trading, an increase of 166% from the average daily volume of 59,314 shares. The stock had previously closed at $1.13.

Analyst Ratings Changes

A number of equities research analysts recently commented on ADGM shares. Lake Street Capital initiated coverage on Adagio Medical in a research report on Tuesday, December 2nd. They set a “buy” rating and a $4.00 price target on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Adagio Medical in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Adagio Medical currently has a consensus rating of “Hold” and a consensus price target of $4.00.

Adagio Medical Price Performance

The company has a quick ratio of 0.68, a current ratio of 0.84 and a debt-to-equity ratio of 1.96. The business’s fifty day moving average is $1.01 and its two-hundred day moving average is $1.17.

Institutional Investors Weigh In On Adagio Medical

Hedge funds and other institutional investors have recently made changes to their positions in the company. Cresset Asset Management LLC acquired a new position in shares of Adagio Medical during the second quarter valued at $39,000. Geode Capital Management LLC increased its position in Adagio Medical by 88.6% in the fourth quarter. Geode Capital Management LLC now owns 68,342 shares of the company’s stock worth $71,000 after purchasing an additional 32,100 shares during the period. Hudson Bay Capital Management LP bought a new stake in Adagio Medical during the 4th quarter worth about $308,000. Armistice Capital LLC acquired a new position in Adagio Medical during the 4th quarter valued at about $497,000. Finally, Adage Capital Partners GP L.L.C. lifted its position in Adagio Medical by 17.3% during the 2nd quarter. Adage Capital Partners GP L.L.C. now owns 821,261 shares of the company’s stock valued at $1,068,000 after purchasing an additional 121,261 shares during the period. 48.08% of the stock is owned by institutional investors and hedge funds.

Adagio Medical Company Profile

Adagio Medical, Inc (NASDAQ: ADGM) is a medical device company focused on the development and commercialization of a noninvasive system for monitoring intracranial pressure (ICP). The company’s proprietary technology uses tympanic membrane displacement to provide clinicians with real-time estimates of ICP without the risks associated with invasive catheter methods. This approach is designed to improve patient safety, reduce complications, and streamline neurological monitoring in acute and critical care settings.

At the core of Adagio Medical’s pipeline is its ADGM System, which is intended for use in hospitals, emergency departments, and other clinical environments where rapid and accurate assessment of ICP is crucial.